The Cleveland Clinic

5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses

CollaboratorPhase 1Not yet recruiting202696 people31 Aug 2026clinicaltrials.gov

NCT07747805

Phase 2Not yet recruiting202630 people5 Aug 2026clinicaltrials.gov

NCT06992440

CollaboratorPhase 2Recruiting202578 people28 May 2025clinicaltrials.gov

NCT06854614

Phase 4Active, not recruiting2025150 people3 Mar 2025clinicaltrials.gov

NCT06802081

Phase 2Recruiting2025100 people30 Jan 2025clinicaltrials.gov

NCT06533527

Phase 4Completed202469 people1 Aug 2024clinicaltrials.gov

NCT06217302

CollaboratorPhase 3Recruiting2024150 people22 Jan 2024clinicaltrials.gov

NCT05832229

CollaboratorPhase 2Recruiting2023260 people27 Apr 2023clinicaltrials.gov

NCT05578508

Phase 1Withdrawn20220 people13 Oct 2022clinicaltrials.gov

NCT04964544

CollaboratorPhase 3Completed20211,196 people16 Jul 2021clinicaltrials.gov

NCT04846231

Phase 2Completed2021203 people15 Apr 2021clinicaltrials.gov

NCT04567225

Phase 4Terminated202039 people28 Sept 2020clinicaltrials.gov

NCT04538352

Phase 4Completed202160 people4 Sept 2020clinicaltrials.gov

NCT04531176

Phase 4Terminated202074 people28 Aug 2020clinicaltrials.gov

NCT04417114

CollaboratorPhase 4Withdrawn20210 people4 Jun 2020clinicaltrials.gov

NCT04073472

Phase 1Withdrawn20210 people29 Aug 2019clinicaltrials.gov

NCT03617458

CollaboratorPhase 2Completed201873 people6 Aug 2018clinicaltrials.gov

NCT03603912

CollaboratorPhase 4Active, not recruiting2018175 people27 Jul 2018clinicaltrials.gov

NCT03527472

CollaboratorPhase 2Completed2018111 people17 May 2018clinicaltrials.gov

NCT03338400

Phase 2Completed201751 people9 Nov 2017clinicaltrials.gov